We are live on ! Find out more
WA

Wasatch Advisors Portfolio holdings

AUM $15.3B
1-Year Est. Return 25.06%
This Fund
S&P 500
This Quarter Est. Return
+22.37%
1 Year Est. Return
+25.06%
3 Year Est. Return
+87.66%
5 Year Est. Return
+80.4%
10 Year Est. Return
+874.7%
AUM
$9.18B
AUM Growth
+$1.67B
Cap. Flow
+$234M
Cap. Flow %
2.55%
Top 10 Hldgs %
23.31%
Holding
235
New
9
Increased
123
Reduced
73
Closed
12

Top Buys

Rank Stock Value
1
VVV icon
Valvoline
VVV
+$56.7M
2
FIVN icon
FIVE9
FIVN
+$35.3M
3
KNX icon
Knight Transportation
KNX
+$32.1M
4
EYE icon
National Vision
EYE
+$30.2M
5
NEOG icon
Neogen
NEOG
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 24.27%
2 Industrials 23.71%
3 Healthcare 16.86%
4 Consumer Discretionary 15.75%
5 Financials 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRPT icon
76
Freshpet
FRPT
$2.83B
$27.5M 0.3%
649,955
+65,505
+11% +$2.52M
DORM icon
77
Dorman Products
DORM
$4.01B
$27M 0.29%
306,002
+42,588
+16% +$3.7M
CYTK icon
78
Cytokinetics
CYTK
$11B
$25.8M 0.28%
3,188,487
+731,682
+30% +$5.38M
ABR icon
79
Arbor Realty Trust
ABR
$960M
$25.6M 0.28%
1,976,450
-373,579
-16% -$4.54M
ESPR
80
DELISTED
Esperion Therapeutics
ESPR
$25.6M 0.28%
637,789
+75,165
+13% +$3.37M
MGNX icon
81
MacroGenics
MGNX
$235M
$23.2M 0.25%
1,291,513
+246,536
+24% +$4.26M
IOSP icon
82
Innospec
IOSP
$2.09B
$22.7M 0.25%
272,262
+1,159
+0.4% +$86.4K
INO icon
83
Inovio Pharmaceuticals
INO
$79.8M
$21.8M 0.24%
487,368
+42,540
+10% +$2.14M
LHCG
84
DELISTED
LHC Group LLC
LHCG
$19.6M 0.21%
176,624
-15,238
-8% -$1.63M
HTHT icon
85
Huazhu Hotels Group
HTHT
$12.4B
$19.3M 0.21%
456,832
-77,034
-14% -$2.63M
SNBR
86
DELISTED
Sleep Number
SNBR
$19.2M 0.21%
408,747
+34,581
+9% +$1.39M
TPIC
87
DELISTED
TPI Composites
TPIC
$19.2M 0.21%
669,539
+67,865
+11% +$2.01M
DNLI icon
88
Denali Therapeutics
DNLI
$3.67B
$19.1M 0.21%
820,904
+775,358
+1,702% +$16.2M
KRNT icon
89
Kornit Digital
KRNT
$706M
$19M 0.21%
799,339
+233,397
+41% +$4.96M
LAD icon
90
Lithia Motors
LAD
$7.78B
$19M 0.21%
204,521
+80,601
+65% +$7.01M
INN
91
Summit Hotel Properties
INN
$761M
$18.7M 0.2%
1,635,993
+268,768
+20% +$2.97M
TNDM icon
92
Tandem Diabetes Care
TNDM
$1.17B
$18.2M 0.2%
286,330
-84,941
-23% -$4.46M
AX icon
93
Axos Financial
AX
$5.45B
$17.7M 0.19%
612,129
+134,904
+28% +$4.04M
HCKT icon
94
Hackett Group
HCKT
$245M
$17.3M 0.19%
1,092,669
+237,597
+28% +$4.07M
ATRA icon
95
Atara Biotherapeutics
ATRA
$71.2M
$17M 0.18%
17,072
+3,065
+22% +$2.85M
IPHI
96
DELISTED
INPHI CORPORATION
IPHI
$16.6M 0.18%
379,598
-65,060
-15% -$2.59M
LOVE icon
97
LoveSac
LOVE
$239M
$15.2M 0.17%
547,510
+46,238
+9% +$1.25M
BAND
98
Bandwidth Inc
BAND
$1.91B
$15.2M 0.17%
227,030
+121,291
+115% +$6.37M
ATRC icon
99
AtriCure
ATRC
$1.77B
$15.1M 0.17%
565,361
+166,578
+42% +$5.06M
MFA
100
MFA Financial
MFA
$929M
$15.1M 0.16%
519,244
+162,735
+46% +$4.71M

Similar funds

Wasatch Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Wasatch Advisors held 235 positions worth $9.18B, up 22% from $7.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Wasatch Advisors's Q1 2019 filing shows 9 new, 123 increased, 73 reduced and 12 closed positions. Its largest new stake was Artisan Partners: 537,695 shares worth $13.5M. The largest sale was Ultimate Software Group Inc, an estimated $131M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Wasatch Advisors's largest Q1 2019 buy was Artisan Partners: 537,695 shares worth $13.5M.
  • Wasatch Advisors added most to Valvoline in Q1 2019, an estimated $56.7M increase.
  • Wasatch Advisors's biggest Q1 2019 reduction was Nu Skin, cutting an estimated $31.4M.
  • Wasatch Advisors fully exited Ultimate Software Group Inc in Q1 2019, selling an estimated $131M.
  • Wasatch Advisors's ten largest holdings make up 23% of its $9.18B portfolio in Q1 2019.
  • Wasatch Advisors opened 9 new positions and closed 12 in Q1 2019.
  • Wasatch Advisors's portfolio value rose 22% quarter-over-quarter to $9.18B.

Based on Wasatch Advisors's 13F filing for Q1 2019, filed 8 May 2019.